Partial response to lorlatinib in thoracic inflammatory myofibroblastic tumor harboring complex and rare ALK fusions: a case report - Tang, Li-Bo; Peng, Ying-Long; Yang, Xiao-Rong; Li, Jia-Ting; Lu, Chang; Zheng, Mei-Mei; Sun, Lu; Yang, Zheng; Yan, Li-Xu; Deng, Yu; Chen, Zhi-Hong; Lv, Si-Di; et al. (Translational lung cancer research, 2025)
Keywords: Case Report; case report; inflammatory myofibroblastic tumor (IMT); lorlatinib; Anaplastic lymphoma kinase (ALK)